We will be treating multiple ailments by the time any of these are approved. And if/when they are they will most likely compliment trofinetide rather than replace it. These are mostly all treatments, not cures! Gene therapy may be a cure but it is at least 10 years away, if ever. Also gene therapy can only specifically target one ailment at a time whereas our drugs can potentially treat almost all neurological disorders.
Competitors to Daybue, page-8
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.68 |
Change
-0.100(0.48%) |
Mkt cap ! $2.643B | |||
| Open | High | Low | Value | Volume |
| $20.50 | $20.74 | $20.01 | $5.091M | 247.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 156 | $20.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.68 | 256 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |